IBD and infliximab: Is this the end of proactive therapeutic drug monitoring?
Bresteau, Clément
IBD and infliximab: Is this the end of proactive therapeutic drug monitoring? - 2022.
78
Syversen SW, Jørgensen KK, Goll GL, et al. Effect of Therapeutic Drug Monitoring vs Standard Therapy During Infliximab Induction on Disease Remission in Patients with Chronic Immune-Mediated Inflammatory Diseases: A Randomized Clinical Trial. JAMA 2021; 325 (17): 1744–54
IBD and infliximab: Is this the end of proactive therapeutic drug monitoring? - 2022.
78
Syversen SW, Jørgensen KK, Goll GL, et al. Effect of Therapeutic Drug Monitoring vs Standard Therapy During Infliximab Induction on Disease Remission in Patients with Chronic Immune-Mediated Inflammatory Diseases: A Randomized Clinical Trial. JAMA 2021; 325 (17): 1744–54
Réseaux sociaux